Neuronetics, Inc. (STIM) stock
STIMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$1.39−0.04 (-2.80%)
Close on Nov 13, 2026Market cap $105.91MP/E –Yield –
Neuronetics operating margin
Operating margin is operating income as a percentage of revenue.
Neuronetics's operating margin for the twelve months ending Sep 30, 2026 was -9.4%. For fiscal 2025 it was -21.1%, against -46.2% the year before. The highest annual figure on record is -21.1% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -21.1% | +25.1 |
| FY2024 | Dec 31, 2024 | -46.2% | −3.3 |
| FY2023 | Dec 31, 2023 | -42.8% | +11.0 |
| FY2022 | Dec 31, 2022 | -53.8% | −4.0 |
| FY2021 | Dec 31, 2021 | -49.8% | −4.5 |
| FY2020 | Dec 31, 2020 | -45.3% | −2.3 |
| FY2019 | Dec 31, 2019 | -43.0% | −5.4 |
| FY2018 | Dec 31, 2018 | -37.6% | −3.9 |
| FY2017 | Dec 31, 2017 | -33.7% | −6.4 |
| FY2016 | Dec 31, 2016 | -27.3% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 1.3% | +20.9 |
| Q2 FY2026 | Jun 30, 2026 | -3.6% | +17.5 |
| Q1 FY2026 | Mar 31, 2026 | -26.1% | +8.3 |
| Q4 FY2025 | Dec 31, 2025 | -12.1% | +38.9 |
| Q3 FY2025 | Sep 30, 2025 | -19.6% | +22.1 |
| Q2 FY2025 | Jun 30, 2025 | -21.1% | +30.6 |
| Q1 FY2025 | Mar 31, 2025 | -34.4% | +4.9 |
| Q4 FY2024 | Dec 31, 2024 | -51.0% | −29.2 |
| Q3 FY2024 | Sep 30, 2024 | -41.7% | +7.9 |
| Q2 FY2024 | Jun 30, 2024 | -51.7% | −10.0 |
| Q1 FY2024 | Mar 31, 2024 | -39.4% | +24.4 |
| Q4 FY2023 | Dec 31, 2023 | -21.8% | +20.7 |
| Q3 FY2023 | Sep 30, 2023 | -49.6% | −4.4 |
| Q2 FY2023 | Jun 30, 2023 | -41.7% | +18.3 |
| Q1 FY2023 | Mar 31, 2023 | -63.8% | +7.7 |
| Q4 FY2022 | Dec 31, 2022 | -42.5% | +3.5 |
| Q3 FY2022 | Sep 30, 2022 | -45.2% | +6.9 |
| Q2 FY2022 | Jun 30, 2022 | -60.0% | −13.8 |
| Q1 FY2022 | Mar 31, 2022 | -71.5% | −15.2 |
| Q4 FY2021 | Dec 31, 2021 | -46.0% | −28.9 |
| Q3 FY2021 | Sep 30, 2021 | -52.0% | −32.6 |
| Q2 FY2021 | Jun 30, 2021 | -46.2% | +24.2 |
| Q1 FY2021 | Mar 31, 2021 | -56.2% | +34.1 |
| Q4 FY2020 | Dec 31, 2020 | -17.1% | +22.9 |
| Q3 FY2020 | Sep 30, 2020 | -19.5% | +20.1 |
| Q2 FY2020 | Jun 30, 2020 | -70.4% | −30.5 |
| Q1 FY2020 | Mar 31, 2020 | -90.3% | −34.9 |
| Q4 FY2019 | Dec 31, 2019 | -40.0% | −3.8 |
| Q3 FY2019 | Sep 30, 2019 | -39.6% | −8.0 |
| Q2 FY2019 | Jun 30, 2019 | -39.9% | −0.4 |
| Q1 FY2019 | Mar 31, 2019 | -55.4% | −10.1 |
| Q4 FY2018 | Dec 31, 2018 | -36.2% | −1.2 |
| Q3 FY2018 | Sep 30, 2018 | -31.5% | −4.8 |
| Q2 FY2018 | Jun 30, 2018 | -39.5% | −14.5 |
| Q1 FY2018 | Mar 31, 2018 | -45.4% | +7.6 |
| Q4 FY2017 | Dec 31, 2017 | -35.0% | – |
| Q3 FY2017 | Sep 30, 2017 | -26.8% | – |
| Q2 FY2017 | Jun 30, 2017 | -25.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -53.0% | – |
See a number that looks wrong?